Drug Shortage Report for ZITHROMAX - PWS ORL 100MG/5ML

Last updated on 2017-04-21 History
Report ID 1360
Drug Identification Number 02223716
Brand name ZITHROMAX - PWS ORL 100MG/5ML
Common or Proper name ZITHROMAX
Company Name PFIZER CANADA ULC
Active Ingredient(s) AZITHROMYCIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size BOTTLE/BOUTEILLE
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-01-20
Estimated end date 2017-04-21
Actual end date 2017-04-20
Shortage status Resolved
Updated date 2017-04-21
Company comments Resolved Apr 20, 2017
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-04-21 English Compare
v5 2017-04-20 French Compare
v4 2017-04-20 English Compare
v3 2017-03-13 French Compare
v2 2017-03-13 English Compare
v1 2017-03-13 English Compare